Abstract-Mammalian cells respond to external stlmuh by activation of a variety of signal transduction pathways, which culmmate m stereotypical responses, such as prohferatlon, growth arrest, hypertrophy, dlfferentlatlon, or apoptosls In vertebrates the actions of many stlmuh resulting m prohferatlve or hypertrophlc growth converge on a set of cellular kmase cancades, which are collectively called the mltogen-activated protein (MAP) kmase cascades These MAP kmases have been implicated m vascular smooth muscle cell prohferatlon and hypertrophy, responses that are central to the pathophyslology of hypertension
T hree MAP kmase cascades have been characterized m mammalian cells (Fig 1) The most well characterized of these 19 the ERK cascade Treatment of vascular smooth muscle cells with growth factors that induce prohferatlon or hypertrophy, such as EGF, PDGF, endothelm, vasopressm, or anglotensm II, activate this pathway Numerous studies have demonstrated that the EKK cascade 1s cntlcal to the mltogemc response, to cellular differentiation, and, m some cells, to the mductlon of hypertrophy The two other MAP kmase cascades are activated by cellular stress One of these cascades 1s called the p54 MAP kmase, the SAPK or JNK pathway Cellular stresses such as oxidant stress, reperfuslon of lschemlc tissue, cell stretch, chear stress, or exposure to inflammatory cytokmes, TNF-a or mterleukm-l/3, or to vasoactlve peptldes mcludmg anglotensm II and endothelm activate this pathway p38 1~ the MAP kmase m the third cascade and 1s the second stress-response MAP kmase p38 1s activated by many of the same stlmuh that activate the SAPK/JNK pathway While these stress-response pathways do not appear to be involved m the transduction of mltogemc signals, they are c!early relevant to the understanding of vascular wall pathology since they transduce growth mhlbltory or apoptotlc signals and may be responsible, m part, for mductlon of the hypertrophlc phenotype in various types of cells When activated, all three MAP kmases have transcrlptlon factors as their primary targets It 1s these transcnptlon factors that regulate the mductlon of sets of genes which determme, m large part, the ultimate blologlcal response of the cell While much has been learned of the pathways controllmg the MAP kmases and the transcrlptlon factors regulated by them, It 1s only recently that we have begun to define the pathophyslological importance of these cascades
ERK Cascade
Kinases and Substrates of the ERK Pathway ERK-1 and ERK-2 were mltlally identified as two protein kmases that became phosphorylated on tyrosme m response to msulm and other growth factors ' This pathway can be activated by stlmulatlon of receptors with mtrmslc tyrosme kmase activity or G-protein-coupled receptors * A number of agents important for control of smooth muscle cell hypertrophy and prohferatlon, vascular resistance, and platelet aggregation activate these kmases These agonists mclude PDGF,' Ang II,3 ET,'-" thromboxane A 2,7 prostaglandm Hz,' prostaglandm F2?,* thrombm,4 norepmephrme,9
and acetylchohne '" The cascade of cellular proteins that results m sequential actlvatlon m the ERK pathway has been established most extensively m cases where the mltlatmg event IS bmdmg of a hgand, such as PDGF, to its receptor which has tyrosme kmase actlvlty A PDGF dlmer bmds to two receptors, fomung a receptor dlmer " The dlmerlzed receptors, with mtrmslc tyrosme kmase activity, then "autophosphorylate" or, more correctly, cross-phosphorylate several tyrosme residues wlthm the receptor '* One phosphotyrosme residue wlthm the kmase domain enhances catalytic activity of the receptor's tyrosme kmase Several other phosphotyrosme residues outside the kmase domain act as docking sites for signal transducmg molecules (Fig 2) These signal transducing molecules interact with the various phosphotyrosme residues on the receptor via SH2 domains, first identified m the nonreceptor tyrosme kmase, Src These SH2 domains are composed of approxlmately 100 ammo acids and Interact with phosphotyrosme residues but not unphosphorylated tyrosme residues When the cell 1s m a resting state, a cytosohc protein, Grb2, which contains an SH2 domain, binds a guanme nucleotlde exchange Selected Abbreviations and Acronyms
Ang II = anglotensln II CREB = CAMP responqe elelnent blndlng protein EGF = epldermal growth factor ERK = extracellular signal-regulated klnase ET endothehn Grb2 = growth factor receptor bound protein 2 JNK = c-Jun N-term& klnase MAP = mltogen-activated protein MAPKAP = mltogen-activated protein klnase activated protrln klnase MKP = mltogen-activated protein klnase phosphatase PDGF = platelet-derived growth factor PI = phosphatldyhnoTlto1 PKC = protein klnase C SAPK = stress-activated proteln klnase SH = Src homology SOS = wn of sevenless TNF = tumor necrosis factor protein, mSOS (the mammahan homolog to Drosoyhrla SOS) through the two SH3 domains of Grb2 and prohne-rich sequences of mSOS l3 When the PDGF receptor 1s tyrosme phosphorylated, the Grb2-mSOS complex 1s recruited to the receptor when the SH2 domain of Grb2 Interacts with a specific region of the receptor, which contains a phosphorylated tyrosme Th15 recruitment of mSOS to the membrane allows mSOS to interact with the small molecular weight GTP-bmdmg (G) protein, Ras, and converts Ras from the GDP-bound @active) to the GTP-bound (active) state Ras-GTP then m turn recruits Raf kmase family members (Raf-I, A-Raf, and B-Raf) l4 Raf-1 binds to Ras VU a region m Its N terminus, residues 51 to 131, contamed m the CR1 regon (conserved region I, which 1s conserved m mammahan, Drosophila, and Caenorh&~&zs elegans Raf homologs) " Raf, when translocated to the membrane, 1~ constltutlvely active but its full actlvatlon depends on addltlonal factors Targeting of Raf-1 to the membrane by attachmg a membrane locahzatlon signal (CAAX box plus a polybaslc domain) 1s sufflclent to activate c-Raf-1, even m the presence of dommant negative Ras li716 However, c-Raf-1 1s not fully activated m this setting unless a growth factor 1s also added Furthermore, comcuba- tlon of purified GTP-loaded Ras with c-Raf-1 falls to activate the latter, consistent with the need for an addltlonal growth factor-activated cofactor to activate c-Raf-1 The moct likely cofactors/activators of c-Raf-1 are the 14-3-3 proteins l7 " When 14-3-3 1s injected mto Xenoytls oocytes, c-Raf-1 becomes activated Actlvatlon of c-Raf-1 m yeast expressmg Ras and c-Raf-1 1s dependent on yeast 14-3-3 proteins The p lsoform of 14-3-3, identified m a yeast two-hybnd screen with c-Raf-2 as the "bait," associates with the N-terminal regulatory domain of c-Raf-1 I') Each 14-3-3 molecule can bmd two c-Raf-1 molecules '"-z The 14-3-3 protein appears to allow c-Raf-1 molecules to interact more effectively when they are brought to the cell membrane by GTP-bound Ras Ohgomerlzatlon of c-Raf-1 1s crltlcal for actlvatlon of c-Raf-1 kmase activity and may bring about cross-phosphorylatlon of one c-Raf-1 molecule by the other *' There remains controversy as to whether ohgomerlzatlon 1s suficlent to activate Raf-1, m which case the role of Ras-GTP 1s to recruit c-Raf so that ohgomers can form, or whether Ras-GTP remains necessary after the formation of ohgomers *",*' Actlvatlon presumably occurs when the mhlbltory ammo-terminal regulatory domain of c-Raf-1, which normally masks the kmase domain, swings out of the way of the kmase domain, freeing It to interact with Its target *' The importance of this regulatory domain of c-Raf-1 1s best seen with truncation mutants of the protein lacking the regulatory domain, such as BXB-Raf, which are highly transformmg 23 24
Activated ERKs phosphorylate and activate at least two transcnpnon factors, c-Myc and Elk-l 37m39 Elk-l and the related SAP-l and SAP-2 are ternary complex factors, which form a complex wth serum response factor and together bmd to the promoter of a number of genes mcludmg c--s that contam the serum response element "' Elk-l, SAP-l, and SAP-2 contam an Ets DNAbmdtng domain 4' 42 Phosphorylahon of each of these protems promotes ternary complex formation and enhances transcnptlonal activating activity, which leads to increased production of c-&OS mRNA " These actwated transcnptlon factors play Cnhd roles tn the mductlon of unmemate early genes and m the mltogemc response The RSK protein kmase fanuly, which are substrates of the ERKs, also translocate to the nucleus when cells are exposed to actlvatorS of the c-Raf-l/ERK cascade 43 One fanuly member, RSK2, may also play an important role m immediate early gene induction and mltogenesls since it appears to phosphorylate CREB at Ser-133, a cntlcal residue for actwahon of CREB and for expression of C-$X m response to some growth factors 44 The existence of Ets domain-contammg transcnptlon factors m Drosop/&, PomtedP2 and Yan, that are also ERK substrates suggests that many other mammahan transcnptlon factors wll be ldennfied which are regulated by this pathway 38 ldenhfymg these substrates, how they are regulated by the ERKs, and what role they play m nutogenesls and hypertrophy ulll hkely offer miportant insight mto these pathophyslologcal responses of the vascular wall G-protein Receptor Activation of the ERK Pathway Many of the agonists that activate the ERK pathway do not interact with receptors with mtrmslc tyrosme kmase activity Rather, agonists such as Ang II, ET, and prostaglandm F?, interact with receptors that are coupled to heterotrlmertc GTP-bmdmg protems The processes responsible for actlvatlon of the ERKs by these receptors have been less well established, although recent progress m this area has provided a great deal of insight In some cell types (eg, Rat 1 cells), activation of the ERK pathway by G-protein-coupled receptors may involve acttvatlon of receptor tyrosme kmases (e g , EGF receptor) via an ill-defined crosstalk mechanism " In most cells, however, actlvatlon of the ERK pathway does not appear to use this mechamsm
In the cases of many agonists, mcludmg Ang II and ET-l, the ERK pathway can be dctlvated by both Ras-dependent and Ras-independent mechanisms with different mechamsm< operant m different cell types (Fig 2) For those cells usmg Rat, the actlvatlon by hgands with heterotnmerlc G-protem-coupled receptors may proceed via LY-or /3y-subumts, depending on the type of receptor Lefkowltz and co-workers"" demonstrated that stlmulatlon of both the a,,,-adrenerglc receptor, which couples to G q,li, or the a?,-adrenerglc receptor, which couples to G,, culmmates m actlvatlon of the ERKs VU a Ras-dependent mechanism, however, the proximal mechanisms utilized by the receptors differ For the G,-coupled receptor, expression of a &subunit sequestermg protem derived from the P-adrenergc receptor kmase blocked agomst-induced Ras, c-Raf-I, and ERK activation, suggesting that P-y mediated activation of the cascade " These data support earlier work showmg that overexpresslon of P-ysubunits, but not constttutlvely active (Y, subumts, activated the ERKs, and that expression of a dommant negative Ras prevented that actlvatlon, placing Ras downstream of /3-y For the G,,, ,-coupled receptor, the @y sequestering /3-adrenerglc receptor kmase peptlde does not prevent ERK actlvatlon, suggesting that (Y<, mediates the activation of Ras How do P-y and olq acnvate Ras' In 1991 we reported that ET, vasopressm, and Ang II signaled via phosphohpase C to enhance tyrosme phosphorylatlon of a number of substrates m rat renal mesangal cells Acnvatlon of protein kmase C was not necesary for this actlvanon of tyrosme phosphorylatlon Wtth this observatlon it was clear that tyrosme phosphorylahon was hkely to be an important component of the stgnalmg pathways of these three agomsts whose mteractlons with cells were medlated via G protein-coupled receptors " Src was the first identified tylosme kmase, which was actwated m response to ET-l Slmonson and co-workers subsequently reported that mductlon of c+s m response to ET-l requires Src and that Ras 1s downstream of Src m this ET-l slgnalmg pathway to the ERKs J71
With the confirmation that Src was ctmcal for lmkmg G-protein-coupled receptors to Ras and ERK actlvatton, two major questions remained (1) How do /3-y or CX,, activate Src and (2) How does Src activate Ras7 A working model (Fig 2) 1s emergmg whereby /3r and a,-mediated actlvatlon of S1 L dnd the rest of the cascade appear to converge very proxnnally at activation of phosphohpase C/3, and the remainder of the pathway to ERK actlvatlon may be shared by many types of receptors m many types of cells Actlvatlon of phosphohpase Cp generates an mcrease in intracellular calcium concentration This calcmm transient then leads to tyrosme phosphorylatlon of a nonreceptor tyrosme kmase, Pyk2 PhosphorvIatton of residue Tyr-402 of Pyk2 allows tt to form a complex with Src via the latter's SH2 domam and results m the activation of Src That these two tyrosme kmases play cntlcal roles m actlvatton of Ras and the ERK cascade IS suggested by mhlbltton of ERK activation m response to occupation of the a,,-adrenergc receptor or the lysophosphatldic acid receptor (G,-lmked), or cy,,,-adrenerglc receptors or bradykmm receptors (G,,-linked) by overexpresslon of Csk (the C-termmal Src k1nas.e that phosphorylates and inactivates Src) or overexpress1on of dominant interfering mutants of Src or Pyk2 47b
Once Src 1s activated, the Src-induced activation of Ras employs many of the same signaling molecules used by the growth factor receptors with 1ntnm1c tyroslne klnase activity After activation of Pyk2 and Src, the adaptor protein She associates with Src, Pyk2, or both, depending on the cell type, v1a interaction of the SH2 domain of She with phosphotyros1ne re$ldues of the klnases After binding to the kinase(s), She then 1s phosphorylated on a tyros1ne residue, which recruits the Grb2/mSOS complex v1a interaction of the SH2 domain of Grb2 with the phosphotyroslne residue of She Alternatively, Grb2/mSOS may be recruited directly by Pyk2 without the intermediary, She As with the growth factor receptors, assoclatlon of the Shc/Grb2/mSOS complex with Src serves to recruit the guanlne nucleotlde exchange factor to the membrane (and thus to Ras) since Src IF 1nembrane associated v1a N-terminal myrlstylatlon
Ras-Independent
Activation of the ERKs
The predommant Ras-independent pathway to ERK actlvanon appears to involve PKC-dependent activation of Raf-1 and, 1n many cells, uses ciasslcal PKC 1soforms that can be downregulated by prolonged incubation of cells with high concentrations of phorbol esters Activation of this PKC-dependent pathway 1s more often associated with G,-linked receptors than with G,-hnked receptors and has been demonstrated with receptors including the ET-l receptor, the vasopressln receptor, the (Y,~-adrenergc receptor, and the ml-muscannlc receptor This pathway appears to be activated by cyq and not Pr since expression of a constitutively active mutant of cq (but not a,) in COS cells activates the c-Raf-1 /ERK cascade Furthermore, Lefkowltz and co-worker?
found that activation of the c-Raf-l/ERK cascade by the G,-coupled a,,,-adrenergc receptor, and the m,-muscanmc receptor were not blocked by expren1on of the /3-adrenergc receptor kmase peptide, a dominant negative form of Ras, or by protein tyroslne kmase inhibitors, but were inhibited by dommant negative c-Raf-l or by PKC depletion wth prolonged phorbol ester treatment Thus 1t appean that G,-coupled receptors can also uthze cq to achvate phospholnosltlde hydrolysis v1a a Ras-mdependent mechamsm, leading to PKC activation and, subsequently, activation of c-Raf-1 (Fig 2) The mechanism of PKC-induced activation of the Raf-l/ ERK cascade 1s not clear Expression of a constltut1vely active mutant of PKCG, or overexpresslon of wild-type PKCE activates the ERK cascade, and the activation 1s Ras-lndependent, but c-Raf-l-dependent, suggesting PKCs might activate c-Raf-1 directly 4x PKC 1soforms have been proposed to be direct activators of c-Raf-1 c-Raf-1 can be phosphorylated by PKCs 1n vitro at Ser-499, a residue within the klnase domain, and this phosphorylat1on 1s associated with activation of c-Raf-1
However, mutation of Ser-499 does not prevent activation of c-Raf-1 1n insect cells when coexp1essed with Ras and Src or activation of c-Raf-1 1n response to a number of stimuli It appears that phosphorylatlon of Raf-1 by PKCs may increase c-Raf-1 autoklnase (or autophosphorylatlng) activity, but not 1ts k1nase activity directed at 1ts phys1ologcal substrate, MEKl In summary, the 51te of action of the PKCs, that can be downregulated by prolonged phorbol ester admlnlstrat1on 1n the G,-activated Ras-independent pathway to activation of the Raf-l/ERK cascade, remains unclear at this tulle, but the act1vatlon 1s likely not to be v1a direct phosphorylatlon of c-Raf-1 Undeistandlng this Ras-independent pathway to ERK activation may be unportant 1n the vasculature since Ang II-mediated activation of the ERKs and enhancement of protein synthesis 1n vascular smooth muscle cells appears to proceed v1a this pathway 3
The role of the novel 1sozymes of PKC, PKC[ and PKCA, 1n signaling by G protein-coupled receptors are unclear These 1sofor1ns are not downregulated by prolonged exposure of cells to phorbol esters, 1nak1ng 1t difficult to study their role 1n llgand-induced activation ofthe ERK cascade A constltutlvely active 1nutant of PKCS 1q capable of activating the ERK (and the SAPK) cascade, and a dommant negative mutant inhibits serum-induced activation of the ERKs Furthermore, Berk and colleagues' propose that PKCl functions as a MEK k1nase and 1s responrlble for activation of the ERK pathway 1n response to Ang II Although these data are intriguing, the importance of the novel PKC 1sozy1nes 1n vascula1 signaling remains to be determined PI-3 klnases 1nay also be involved 1n the signaling cascade from G protein-linked receptors to Ras " One type of PI-3 k1nase 1s activated by growth factors This PI-3 k1nase consists of a heterodlmer of a ~110 catalytic subunit and a ~85 adapter protein, which mediates binding to growth factor receptors and to IRS-l v1a 1ts SH2 domain PI3Ky does not appear to interact with ~85 subunits, but can be activated 1n vitro by either (Y-or py-subunits of G-proteins /3y-subumts recruit PISKy to the membrane where 1ts aubstrates are located PI3Ky then activates Src or a Src-hke klnase, which then triggers tyroslne phosphorylat1on of She, 1ts assoclat1on with Grb2/mSOS, and activation of Ras and the c-Raf-l/ERK cascade These studies of the role of PI3Ky were performed with the G,-linked 1n2 muscarm1c receptor There may be an important role for the arachldonlc acid metabohc pathways 1n Ang II-mediated activation of ERK1/2 klnase and 1n1togenesls It has been reported that the 12-hpoxygenase pathway of arachtdonate metabolism plays a cnt1cal role 1n the hypertrophlc effects of Ang II 1n vascular smooth muscle cells '" In Chinese hamster ovary cells transfected with the Ang II receptor, Ang II Induces a b1phas1c increase m ERKI /2 klnase activity " Inhibitors of the 12-hpoxygenase pathway inhibit mltogenesls as well as the sustained late peak of ERKl/2 activation Furthermore the 12-llpoxygenase product, 12-hydroxyelcosatetraenolc acid, increases ERKl/2 activity and 1ncreaqes cell prohferatlon Hyperplasia, Hypertrophy, and Interaction of the ERK Cascade With the Cell Cycle Expression of constltutlvely active forms of Ras, c-Raf-1, or MEK-1 are sufliclent to activate mltogenesls 1n fibroblasts "" Furthermore, expres51on of do1nmant Inhibitory mutants of Ras, c-Raf-1, and MEK-1 block growth factor-mduced mltogenesis These data confirm the critical importance of this cascade 1n the mltogenlc response Furthermore, smce active MEK-1 1s sufficient to induce mltogenesls, 1t 1s likely that the ERKs are the key downstream kmases promotmg cell cycle progression rather than components of a dIvergent pathway activated by Ras or c-Raf-1 Sustained, as opposed to transient, activation of the ERKs appears to be required for many cells to pass the G, restnctlon point and to enter S phase, m which cellular DNA 1s rephcated 54 55 Although ERK actlvatlon 1s linked to the cell cycle, it had not been clear where the c-Raf-l/ERK pathway might interact with the cell cycle machinery Expression of the D-type cychns, which are the regulatory (activating) subunits for the cychn-dependent kmase 4 and 6 (cdk4 and cdk6) catalytic subunits, appear to control the early stages of the transition toward S phase Levels of D type cychns rise m response to growth factor stlmulatlon " A cntlcal hnk between sIgna transduction and the cell cycle has recently been suggested by the finding that expression of dominant mhlbltory mutants of MEK-1 or ERK-1 or expression of the MKP-1, which dephosphorylates and inactivates the ERKs (see below), inhibited growth factor-dependent expression of cychn Dl Expression of a constltutlvely active mutant of MEK-1 or various Raf constructs increased cyclm D 1 expression 57-5'J Although the mechamsms are not known, activation of the Raf/ERK cascade also correlates with mcreased expression of cychn E (the regulatory subunit of cdk2) and decreased expression of the cychn-dependent kmase mhlbltor ~27~"' These data suggest the Raf/ERK cascade may interact at multiple sites to induce cell cycle progression Surpnsmgly, m NIH3T3 cells, the ability of vanous Raf proteins to induce prohferatlon 1s inversely correlated with their ability to activate the ERKs Raf proteins which induce prohferatlon, only weakly activate the ERKs, and strong activators of the ERKs can induce cell cycle arrest m G, The ability of the Raf constructs to induce cell cycle arrest 1s highly correlated with their ability to induce expression of the cychn-dependent kmase mhlbltor, p21"'"', which mhlblts activity of the cychn D-cdk4 and cychn E-cdk2 complexes w") These mtrlgumg data suggest a mechanism that may explain the ability of the c-Raf-l/ERK cascade to signal either mltogenesls or cell cycle arrest and dlfferentlatlon and suggest that this decision depends, at least m part, on the strength of activation of the pathway Clearly, the decision of a cell to enter the cell cycle or undergo cell cycle arrest and dlfferentlatlon also depends on the cell type since transgemc mice expressing constltutlvely active Ras m the skm show enhanced dlfferentlatlon of keratmocytes whereas those expressing Ras m the pancreas and liver show enhanced prollferatlon
In the heart, hypertrophlc cardiomyopathy may involve activation of the ERK pathway since transgemc mice expressing constltunvely active Ras m then left ventricle develop cardiac hypertrophy and dlastohc dysfunction "' On the other hand, when the hypertrophlc response 1s evaluated by momtonng reporter gene expression that 1s under control of the atria1 natnuretlc factor or myosm hght chain-2 kmase promoters m cardiac cells, constltutlvely active MEK does not induce gene expression and mhlblts expression that 1s mduced by the hypertrophlc stmmlus, phenylephrme "
Tutwing the ERK Puthtuay OCg
The lmk between the ERK pathway and cell growth strongly suggests that cells must have regulated mechanisms for turning the ERK pathway off6* Cells use at least two mechamsms to turn off the ERKs, both ofwhlch hmlt the mltogemc response Incubation of activated ERKs with either serme/threomne or tyrosme phosphatases m vitro mactlvates the kmases Dual speclficlty phosphatases (actmg on both Ser/Thr and Tyr residues), the MKPs, probably mactlvate the ERKs m vwo " " Regulation of MKP-1 activity appears to be predominantly at the level of transcnptlon and marked increases m MKP-1 mRNA are seen within the first 60 minutes after exposure of cells to mltogens Overexpresslon of MKP-1 mhlblts Ras-and serum-induced DNA synthesis, lmphcatmg MKP-1 as a major negative modulator of the mltogemc response to agonists which act via Ras 63 Ang II induces the expression of MKP-1 m vascular smooth muscle cells h5 Antisense ohgonucleotldes to MKP-1 mhlblt MKP-1 expresslon and result m prolonganon of the Ang II-induced ERKl/2 activation, lmphcatmg MKP-1 as a dominant ERKl/2 phosphatase m vlvo 15 The second mechanism that hmlts ERK actlvatlon involves the CAMP-dependent protein kmase, protein kmase A Increases m cellular CAMP levels inhibit growth factor-induced prohferatlon of vascular smooth muscle cells CAMP-activates protein kmase A, which antagonizes PDGF-induced ERK activation m human arterial smooth muscle cells without affectmg receptor tyrosme phosphorylatlon or phosphohpace C activation " This mhlbltlon 1s due, at least m part, to prevention of Ras-dependent actlvatlon of c-Raf due to mhlbltlon of the coupling of GTP-loaded Ras to c-Raf-1 " 6X Protein kmase A phosphorylates c-Raf-1 on Ser-43 within the regulatory domain of the protein This phosphorylatlon reduces the affinity with which c-Raf-1 binds to Ras " Protein kmase A also activates Rapl, a small molecular weight G-protein m the Ras superfamily, which mhlblts actlvatlon of Raf-1 ") Other mechamsms may play a role m the antagonism of CAMP on the response to Ang II Takahashl et a17" have reported that CAMP antagonizes the hypertrophlc response of vascular smooth muscle cells to Ang II without affecting Ras and MAP kmase activation "' Given the pleotrophlc effects of CAMP, this could be explained by other signaling pathways or other effects of CAMP on transcription factors Some drugs also mhlblt the ERK pathway Heparm 1s a potent mhlbltor of vascular smooth muscle prollferatlon " " Heparm mhlblts PDGF-induced tyrosme phosphorylatlon and actlvatlon of ERK1/2 at later time points without altenng phosphorylatlon of the PDGF receptor or early activation of ERKl/2 " Hepann mhlblts PDGF-induced phosphorylatlon of c-Raf-1 and does not stimulate tyrosme phosphatases 7' Novel Insulin-sensltlzmg agents, thlazohdmedlones, have been demonstrated to mhlblt msuhn-, EGF-and basic fibroblast growth factor-induced growth of vascular smooth muscle cells 74 Troghtazone, a member of this family of agents, and related agents attenuate hypertension m a number of animal models 75~76 Troghtazone mhlblts basic fibroblast growth factor-induced prohferatlon and C-$X mductlon and mhlblts neomtlmal thickening after aorttlc balloon inJury The effect on c-j& gene mductlon was associated with mhlbltlon of Elk-l activation, which was apparently due to mhlbltlon of ERKl/2 phosphorylatlon of Elk-l " However, there was no mhlbmon of ERKl/% kmase actlvlty, placing the mhlbltlon of Elk-l phosphorylatlon at a site distal to the ERKs This group also Two other families of MAP kmases are nutnmally activated by classic growth factors but potently activated by cellular stresses and by agonists that play important roles m hypertension including Ang II, ET-l, and a-adrenerguz agents One family has been designated SAPKs (which has 54-and 46-kD lsoforms encoded by at least three genes), since they were activated by cellular stress, or JNK, based on the ability of the kmase to phosphorylate the ammo terminus of c-Jun ")eA3 The other family includes lsoforms of ~38, the mammalian homolog of HOG-l, a yeast kmase involved m the response to osmolar stress Like ERK1/2, the SAPKs and p38 are prohne directed and require phosphorylatlon on both tyrosme and threonme residues for activation 81 Unlike the TEY motif of the ERKs, the SAPKs contain a TPY motif and p38 a TGY motif within kmase subdomam VIII which, when phosphorylated, activates the kmases Overall, there 1s 40% to 50% identity m the catalytic domains when comparing the ERKs, SAPKs, and p38 83 p38 and the SAPKs are activated by many of the same cellular stresses including inflammatory cytokmes (TNF-a and mterleukm-l/3), heat shock, osmolar stress, ultraviolet and lomzmg radiation, cell stretch, and shear stress 7')~8'1~x' However, differences m activation patterns do exist For example, we found that the SAPKs are not activated by lschemra alone, but are markedly activated by reperfuslon of lschemlc kidney t(4,85 In contrast, p38 1s activated during the lschemlc phase m kidney and heart but activity declines during reperfuslon. R4-86 The SAPKs are also activated m the artenal wall of aortlc, carotid, and femoral arteries by acute hypertension m rats whether the hypertension 1s caused by Ang II or phenylephrme infusion *' The vasoactlve peptides, Ang II, m liver eplthehal cells, and endothelm, m an-way smooth muscle cells and glomerular mesangal cells, activate the SAPKs and, of note, SAPK activation 1s greater than ERK actlvatlon "-"' These data raise the posslblhty that the SAPKs may be a major signaling arm of the vasoactlve peptldes and suggest that these kmases might play a role m the hypertrophlc adaptation of myocytes, vascular smooth muscle cells, and renal mesangal cells 82
The signaling cascades resulting m SAPK/JNK and p38 activation have direct parallels with the ERK cascade, but the cascades are relatively insulated from one another since the MEKs that activate one MAPK are much less effective at activating the others (Fig 1) and thus function as MEKKs 8"18' This diversity of upstream activators probably reflects the incredible diversity of stimuli that converge at activation of the SAPKs MEKKs m the p38 cascade have not been clearly identified
The signaling components upstream of the MEKK level are also likely to be quite different, depending on the stimulus (eg, osmolar stress versus inflammatory cytokmes) However, for the vasculature and its adaptation to hypertension, one family of kmases highly conserved throughout evolution 1s likely to play a cntlcal role We and Bokoch and co-workers""" first demonstrated that two kmases from the Stenle20 (Ste20) family (so named because yeast with mutations m the STE20 gene do not mate normally m response to pheromone) could activate the SAPK and p38 cascades ')596 One of these kmases, germinal center kmase, 1s a member of a growing subfamily of Ste20-like kmases, many of which activate the SAPKs Although the physlologcal role of most of these kmases 1s not known since activators have not been identified, germinal center kmase probably plays a role m SAPK activation by TNF-a and possibly other inflammatory cytokmes "' The other Ste20 family member likely to play a role m hypertension 1s the p21 activated kmase p21 activated kmase 3 1s regulated by small G-proteins of the Ras superfamily, Racl and Cdc42Hs. The p21 activated kmases are also regulated by some heterotnmenc G-protein-coupled receptors, making them ideal candidates for regulating SAPK and, possibly, p38 actlvatlon by the vasoactlve peptldes
Targets of the Stress Response MAP Kinases
Like the ERKs, after phosphorylatlon and actlvatlon, the SAPKs and p38 translocate to the nucleus where they phosphorylate and activate several targets Transcnptlon factors are major targets of the SAPKs and p38 The SAPKs phosphorylate c-Jun on Ser-63 and Ser-73, two residues within the transcnptlonal actlvatlon domain, and this enhances transactlvatmg activity of c-Jun The SAPKs also phosphorylate the transcnptlon factor ATF-2 Like c-Jun, ATF-2 contains an N-terminal transcriptional activation domain and phosphorylatlon by the SAPKs (or ~38) at Thr-69 and Thr-71 within this domain enhances the transcnptlonal actlvatmg activity of ATF-2 That the SAPKs are physlologlcally relevant ATF-2 kmases 1s
suggested by the observation that the SAPKs are the predominant ATF-2 transactlvatlon domain kmases m postlschemlc kidney " ATF-2 can form homodlmers or heterodlmers with other members of Its family, ATF3 and CREB, or with c-Jun or NF-kB, suggesting it may play a role m the actlvatlon of transcription from many promoters For example, a c-Jun/ ATF-2 dlmer appears to control mductlon of c-lun m response to cellular stresses, and it 1s likely that the SAPKs transduce this sIgna by phosphorylatmg both transcrlptlon factors In addltlon, mterleuku-l-induced transcnptlon of the gene encoding the adhesion molecule, E-selectm, 1s regulated, at least m part, by a c-Jun/ATF-2 dlmer acting at the NF-ELAMl site of the E-selectm promoter Like the ERKs, the SAPKs and ~38 phosphorylate the ternary complex factor, Elk-l, within the C-terminal actlvanon domain which enhances ternary complex formation, DNA binding, and transcnptlonal activating activity ofElk-"' Because all three MAP kmases activate Elk-l and because ternary complex formation at the SRE of the c-fos promoter controls, at least m part, c+s mductlon, it 1s not surpnsmg that c-j& 19 induced m response to such a wide variety of stmmh
The gene encoding collagenase 1s regulated by an AP-1 site wlthm the promoter, which binds a c-Jun/c-Fos dlmer Because the SAPKs activate c-Jun and Elk-l, the latter leading to increased production of c-Fos, stlmuh that recruit the SAPKs are potent inducers of the gene encoding collagenase X2
Although the SAPKs and ~38 share many substrates, then substrate specificity 1s not identical since c-Jun 1s a SAPK (but not ~38) target and the transcnptlon factors SAP-1 and CHOP, a transcrlptlon factor mvolved m stress-induced Gl arrest, are p38 (but not SAPK targets) 'I7 ~38 also phosphorylates and activates MAPKAP kmase-2 and -3 Like the ERKs, which control acnvatlon of CREB via actlvatlon of the protein kmase, RSK2, the ~38 pathway may control activation of CREB and the related ATF-1 via MAPKAP kmase-2 "' MAPKAP kmase-2 phosphorylates CREB at Ser-133, mcreasmg transcnptlonal actlvatmg activity of CREB ')' CREB 1s phosphorylated on Ser-133 after cellular stress It 1s hkely that this 1s mediated via activation of ~38 and its target, MAPKAP kmase-2, since the ~38 mhlbltor, SB203580, markedly mhlblts CREB phosphorylatlon and actlvatlon "' MAPKAP kmase-2 also phosphorylates the small heat shock protein, Hsp25/HSP27, whose phosphorylatlon IS a prominent part of the response to cytokmes, cellular stress (ATP depletion, heat shock, etc ), and some growth factors While the physlologcal significance of the phosphorylatlon 1s unknown and the function of Hsp25/HSP27
1s not clear, it likely plays a protective role m the cell p38 has other substrates with roles m signal transduction and the response to stress ~38 plays an important role m the aggregation of platelets in response to a variety of agonists since pretreatment of platelets with SB203580 mhlblts aggregation ')') ""' This has been postulated to be related to phosphorylatlon by ~38 of a cntlcal residue (Ser-505) of cytosohc phoqphohpase AZ, a residue that 1s also phosphorylated by the ERKs ""I Phosphorylatlon of this residue by the ERKs has been reported to increase the activity of cytosohc phosphohpase AZ
Biological Effects of SAPK/p38 Activation
Although insights mto the blologcal function of the SAPKs and ~38 can be gamed by identifying downstream targets, this approach has hmltatlons For example, although the SAPKs and ~38 clearly play a role m c-JWZ and cTfis mductlon, these IE gene5 are induced m response to such a wide variety of stimuli that it 1s dlfflcult to draw any conclusions about the specific blologlcal responses initiated by the kmases These must be examined directly Based on a series of studies, it 1s now clear that actlvatlon of the SAPK and/or ~38 cascades can tngger apoptosls or programmed cell death '"' A wide array of stlmuh, including withdrawal of nerve growth factor from PC12 cells, oxidant stress, lomzmg radiation, and TNF-a, induce apoptosls m susceptible cells Because expression of dominant mhlbltory mutants of components of the SAPK or ~38 pathways can block apoptosls, and expression of constltutlvely active components can induce apoptosls, it 1s likely that these pathways transduce cntlcal signals m the response to certain apoptotlc stimuli In PC12 cells, expression of constitutively active MEKl, the nnmedlate upstream activator of the ERKs, prevents apoptosls induced by nerve growth factor withdrawal, suggesting that the decision to inmate apoptosls or not may depend on the balance between anti-apoptotlc signals transduced by the ERK cascade and pro-apoptotlc signals transduced by the SAPK/p38 cascades c-Raf-1 may be involved as well since it phosphorylates and mactlvates the pro-apoptotlc Bcl-2 family member, Bad '"2,'"3
The role of apoptosls m the pathogenesls of or adaptation to hypertension 1s only starting to be explored Increasing evldence suggests that apoptosls may be a prominent component of lschemla-induced cardlomyocyte cell death and m the progression of ldlopathlc, lschemlc, and hypertensive cardlomyopathy "I4 It will be cntlcal to the understanding of these and other processes, such as vascular remodeling and the evolution of the atherosclerotic plaque, to determine the roles played by the SAPKs, ~38, and the ERKs m their development It seems likely that the SAPKs and ~38 will also play a prominent role m the mductlon of the hypertrophlc phenotype m susceptible cells Although relatively little work has been done m vascular smooth muscle cells, studies using neonatal rat ventricular myocytes have demonstrated that expression of constltutlvely active MEKKl induces an increase m myocyte size and transcnptlonal changes charactenstlc of the hypertrophlc response (increased promoter activity of the "marker" genes, atnal natnuretlc factor, P-myosm heavy chain, and skeletal muscle a-actm) "I5 It 1s likely, however, that the SAPK cascade 1s not solely responsible for full mductlon of the hypertrophlc response, since another marker of the hypertrophlc response, an increase m orgamzatlon of the myofilamerits, was not seen after transfectlon of MEKK1"'S In some cells, actlvatlon of the p38 or SAPK cascade does not induce mltogenesls, apoptosls, or hypertrophy, but causes cell cycle arrest at the G,/S transltlon '"' ~38 may induce cell cycle arrest by mhlbltmg the mductlon of G, cyclms ;' These data suggest that the stress response kmase pathways might also force cells out of the cell cycle, toward a postmltotrc, differentlated phenotype The balance between ERK actlvatlon and Force and Banventre 2.59 p38 or SAPK activation may help determine, m part, whether the cell decides to respond to a particular stimulus by undergoing cell cycle arrest/&fferentlatlon or by reentering the cell cycle Thus, the cell's response to agents, such as Ang II and ET-l, which can induce either the hypertrophlc phenotype or mltogenesls, may depend on the balance between actlvatlon of these pathways Determining how the cell makes this decision 19 clearly one of the most mlportant challenges m the field
Conclusions
Many of the components of the MAP kmase pathways from cell surface receptors or cellular stress to the nucleus have now been identified Although certam components remam unclear (eg, the MEKKs m the p38 pathway), and these need to be identified, it 1s our opmlon that the cntlcal issues to be addressed m hypertension research are 2-fold (1) determine what are the proximal components that transduce the signals from relevant G-protein-coupled receptors (Ang II, endothehn, etc ) and stress (eg, cell stretch, etc ) to actlvatlon of stress-response kmase pathways, and (2) determine the blologlcal responses regulated by actlvatlon of these kmases and how those responses might be altered Many questions need to be answered, including how do growth factors cause mltogenesn m one cell and hypertrophy m another, what role do the ERKs, SAPKs, and p38 play m hypertrophy, and how does the cell decide to respond to SAPK/p38 activation by undergoing apoptosls versus cell cycle arrest versus hypertrophy? Although these and other questions can mltlally be examined m vitro, ultimately the observations made m cultured cell? will need to be confirmed m the intact animal For this purpose, strategies likely to produce answers include expressing dominant mterfermg mutants of a MAPK pathway under the control of mduclble promoters m an organ or tissue specific manner, or the use of better pathway-specific pharmacological mhlbltors With these complementary approaches, we may be able to dissect the role of these pathways m the progresslon of hypertensive cardiovascular disease and to define therapeutic strategies to alter that progression Acknowledgments 
